Literature DB >> 2410071

Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.

W l McGuire, J S Meyer, B Barlogie, T E Kute.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2410071     DOI： 10.1007/bf01805985

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  9 in total

1.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

2.  Epidermal growth factor receptors and prognosis in primary breast cancer.

Authors:  F Spyratos; J C Delarue; C Andrieu; R Lidereau; M H Champème; K Hacène; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

3.  Methylthioadenosine phosphorylase in human breast cancer.

Authors:  R Smaaland; J S Schanche; S Kvinnsland; J Høstmark; P M Ueland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

4.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Prognostic factors for recurrence and survival in human breast cancer.

Authors:  W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

6.  Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients.

Authors:  M Namer; A Ramaioli; X Fontana; M C Etienne; M Héry; A Jourlait; G Milano; M Frenay; E François; F Lapalus
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

7.  Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67.

Authors:  W Weikel; T Beck; M Mitze; P G Knapstein
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872

8.  Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.

Authors:  W Biddle; E J Sarcione
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

9.  Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.

Authors:  G Gasparini; S Dal Fior; F Pozza; P Bevilacqua
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.